APA

Martínez Del Prado P., Alvarez-López I., Domínguez-Fernández S., Plazaola A., Ibarrondo O., Galve-Calvo E., Ancizar-Lizarraga N., Gutierrez-Toribio M., Lahuerta-Martínez A. & Mar J. (2018). Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals. : ClinicoEconomics and outcomes research : CEOR.

Chicago

Martínez Del Prado Purificación, Alvarez-López Isabel, Domínguez-Fernández Severina, Plazaola Arrate, Ibarrondo Oliver, Galve-Calvo Elena, Ancizar-Lizarraga Nerea, Gutierrez-Toribio María, Lahuerta-Martínez Ainhara and Mar Javier. 2018. Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals. : ClinicoEconomics and outcomes research : CEOR.

Harvard

Martínez Del Prado P., Alvarez-López I., Domínguez-Fernández S., Plazaola A., Ibarrondo O., Galve-Calvo E., Ancizar-Lizarraga N., Gutierrez-Toribio M., Lahuerta-Martínez A. and Mar J. (2018). Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals. : ClinicoEconomics and outcomes research : CEOR.

MLA

Martínez Del Prado Purificación, Alvarez-López Isabel, Domínguez-Fernández Severina, Plazaola Arrate, Ibarrondo Oliver, Galve-Calvo Elena, Ancizar-Lizarraga Nerea, Gutierrez-Toribio María, Lahuerta-Martínez Ainhara and Mar Javier. Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals. : ClinicoEconomics and outcomes research : CEOR. 2018.